[Anorexia nervosa and its consequences on bone: a therapeutic challenge].
It has been estimated that osteoporosis is present in 20 to 50% of women with anorexia nervosa, with an increased fracture risk particularly at non vertebral sites. Thus, bone loss is a major clinical concern in anorexia nervosa patients, justifying systematic evaluation. However, evidence-based therapeutic options are limited.
Service des maladies osseuses, Centre collaborateur de I'OMS pour la prevention de l'ostéoporose, Département de réhabilitation et gériatrie, HUG, 1211 Gèneve. andrea.trombetti@hcuge.ch
Andrea
A
Trombetti
Laura
L
Richert
René
R
Rizzoli
D015502:Absorptiometry, Photon; D000293:Adolescent; D000328:Adult; D000856:Anorexia Nervosa / Q000150:complications* / Q000503:physiopathology; D018488:Bone Demineralization, Pathologic / Q000188:drug therapy / Q000209:etiology*; D015519:Bone Density / Q000502:physiology; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D016723:Bone Remodeling / Q000502:physiology; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D012307:Risk Factors; D014807:Vitamin D / Q000627:therapeutic use; D015430:Weight Gain
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004967:Estrogens; D014807:Vitamin D; D002118:Calcium